Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer

Breast cancer (BC) is the most common cancer in women and second only to lung cancer in terms of mortality. Among the three different BC subtypes, the oestrogen receptor positive represents nearly 70% of all cases and it is usually treated with anti-oestrogen drugs. However, the majority of hormone...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobhani, Navid, Generali, Daniele, Zanconati, Fabrizio, Bortul, Marina, Scaggiante, Bruna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314865/
https://www.ncbi.nlm.nih.gov/pubmed/30622925
http://dx.doi.org/10.5306/wjco.v9.i8.172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314865/
https://www.ncbi.nlm.nih.gov/pubmed/30622925
http://dx.doi.org/10.5306/wjco.v9.i8.172

Ejemplares similares